Spinal Modulation Reaches Deal With St. Jude For Option To Buy
This article was originally published in The Gray Sheet
Executive Summary
St. Jude pays $40 million for exclusive international distribution rights to Spinal Modulation’s Axium spinal cord stimulation technology and may someday buy the whole company for $300 million.